OBJECTIVE: To test the effects of maternal periodontal disease treatment on the incidence of preterm birth (delivery before 37 weeks of gestation). METHODS: The Maternal Oral Therapy to Reduce Obstetric Risk Study was a randomized, treatment-masked, controlled clinical trial of pregnant women with periodontal disease who were receiving standard obstetric care. Participants were assigned to either a periodontal treatment arm, consisting of scaling and root planing early in the second trimester, or a delayed treatment arm that provided periodontal care after delivery. Pregnancy and maternal periodontal status were followed to delivery and neonatal outcomes until discharge. The primary outcome (gestational age less than 37 weeks) and the secondary outcome (gestational age less than 35 weeks) were analyzed using a chi test of equality of two proportions. RESULTS: The study randomized 1,806 patients at three performance sites and completed 1,760 evaluable patients. At baseline, there were no differences comparing the treatment and control arms for any of the periodontal or obstetric measures. The rate of preterm delivery for the treatment group was 13.1% and 11.5% for the control group (P=.316). There were no significant differences when comparing women in the treatment group with those in the control group with regard to the adverse event rate or the major obstetric and neonatal outcomes. CONCLUSION:Periodontal therapy did not reduce the incidence of preterm delivery. LEVEL OF EVIDENCE: I.
RCT Entities:
OBJECTIVE: To test the effects of maternal periodontal disease treatment on the incidence of preterm birth (delivery before 37 weeks of gestation). METHODS: The Maternal Oral Therapy to Reduce Obstetric Risk Study was a randomized, treatment-masked, controlled clinical trial of pregnant women with periodontal disease who were receiving standard obstetric care. Participants were assigned to either a periodontal treatment arm, consisting of scaling and root planing early in the second trimester, or a delayed treatment arm that provided periodontal care after delivery. Pregnancy and maternal periodontal status were followed to delivery and neonatal outcomes until discharge. The primary outcome (gestational age less than 37 weeks) and the secondary outcome (gestational age less than 35 weeks) were analyzed using a chi test of equality of two proportions. RESULTS: The study randomized 1,806 patients at three performance sites and completed 1,760 evaluable patients. At baseline, there were no differences comparing the treatment and control arms for any of the periodontal or obstetric measures. The rate of preterm delivery for the treatment group was 13.1% and 11.5% for the control group (P=.316). There were no significant differences when comparing women in the treatment group with those in the control group with regard to the adverse event rate or the major obstetric and neonatal outcomes. CONCLUSION: Periodontal therapy did not reduce the incidence of preterm delivery. LEVEL OF EVIDENCE: I.
Authors: Bryan S Michalowicz; James S Hodges; Anthony J DiAngelis; Virginia R Lupo; M John Novak; James E Ferguson; William Buchanan; James Bofill; Panos N Papapanou; Dennis A Mitchell; Stephen Matseoane; Pat A Tschida Journal: N Engl J Med Date: 2006-11-02 Impact factor: 91.245
Authors: Patricia Weidlich; Carlos Heitor C Moreira; Tiago Fiorini; Marta L Musskopf; José M da Rocha; Maria Lucia R Oppermann; Anne M Aass; Per Gjermo; Cristiano Susin; Cassiano K Rösing; Rui V Oppermann Journal: Clin Oral Investig Date: 2013-01 Impact factor: 3.573
Authors: Kristen S Marchi; Susan A Fisher-Owens; Jane A Weintraub; Zhiwei Yu; Paula A Braveman Journal: Public Health Rep Date: 2010 Nov-Dec Impact factor: 2.792
Authors: David A Albert; Melissa D Begg; Howard F Andrews; Sharifa Z Williams; Angela Ward; Mary Lee Conicella; Virginia Rauh; Janet L Thomson; Panos N Papapanou Journal: Am J Public Health Date: 2010-11-18 Impact factor: 9.308